Si-Bone

Si-Bone company information, Employees & Contact Information

Explore related pages

Related company profiles:

SI-BONE® is focused on helping patients in one of the most under-served, under-diagnosed, and under-treated areas in orthopedics, the sacroiliac (SI) joint. SI-BONE developed an innovative, patented implant to fuse the SI joint. The iFuse Implant System® provides a less invasive alternative to traditional sacroiliac (SI) joint fusion surgery and has been used in over 65,000 procedures to date. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For additional information on the company or the products including risks and benefits, please visit www.si-bone.com/risks. We are aware of active recruitment scams using the SI-BONE name, in which individuals pose as our recruiters and post fake remote job openings and make fake job offers on the Internet. Please note, we will never make an offer of employment without conducting multiple rounds of interviews face-to-face using secure video-conferencing technology. We will never ask candidates to cash checks or make a payment in order to be considered for a position. SI-BONE only uses company email addresses, which contain “@si-bone.com” to communicate with candidates. If you believe you’ve been a victim of a phishing scam, please visit the Cybersecurity & Infrastructure Security Agency at https://www.cisa.gov/be-cyber-smart/report-incident learn how to report it.

Company Details

Employees
531
Founded
-
Address
471 El Camino Real,
Phone
4085578312
Email
in****@****ONE.com
Industry
Medical Device
HQ
Santa Clara, California
Looking for a particular Si-Bone employee's phone or email?

Si-Bone Questions

News

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025 - GlobeNewswire

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025 GlobeNewswire

SI-BONE (Nasdaq: SIBN) sets Third Quarter results call at 4:30 p.m. ET; 90-day replay - Stock Titan

SI-BONE (Nasdaq: SIBN) sets Third Quarter results call at 4:30 p.m. ET; 90-day replay Stock Titan

SI-BONE, Inc. To Report Q2 2025 Financial Results and Host Conference Call on August 4, 2025 - Quiver Quantitative

SI-BONE, Inc. To Report Q2 2025 Financial Results and Host Conference Call on August 4, 2025 Quiver Quantitative

SI-BONE Inc (SIBN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Positive ... - Yahoo Finance

SI-BONE Inc (SIBN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Positive ... Yahoo Finance

SI-BONE, Inc.: Small-cap Developer Of Medical Implants And A Steady Revenue Grower (SIBN) - Seeking Alpha

SI-BONE, Inc.: Small-cap Developer Of Medical Implants And A Steady Revenue Grower (SIBN) Seeking Alpha

SI-Bone, Inc. Data Breach Affects PII & PHI - Claim Depot

SI-Bone, Inc. Data Breach Affects PII & PHI Claim Depot

SI-BONE’s SWOT analysis: stock poised for growth amid market challenges - Investing.com

SI-BONE’s SWOT analysis: stock poised for growth amid market challenges Investing.com

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance - The Globe and Mail

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance The Globe and Mail

SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™ - Ortho Spine News

SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™ Ortho Spine News

SI-BONE Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

SI-BONE Second Quarter 2025 Earnings: Beats Expectations Yahoo Finance

Medical Device Leader SI-BONE to Present at Morgan Stanley's 23rd Global Healthcare Conference in NY - Stock Titan

Medical Device Leader SI-BONE to Present at Morgan Stanley's 23rd Global Healthcare Conference in NY Stock Titan

SI-BONE, Inc.'s (NASDAQ:SIBN) P/S Still Appears To Be Reasonable - 富途牛牛

SI-BONE, Inc.'s (NASDAQ:SIBN) P/S Still Appears To Be Reasonable 富途牛牛

DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating - GlobeNewswire

DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating GlobeNewswire

SI-Bone Data Breach Lawsuit Investigation - Claim Depot

SI-Bone Data Breach Lawsuit Investigation Claim Depot

SI-BONE, Inc. Announces U.S. Military's TRICARE Now Covers MIS SI Joint Fusion - PR Newswire

SI-BONE, Inc. Announces U.S. Military's TRICARE Now Covers MIS SI Joint Fusion PR Newswire

SI-BONE, Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:SIBN) 2025-08-04 - Seeking Alpha

SI-BONE, Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:SIBN) 2025-08-04 Seeking Alpha

SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation - Ortho Spine News

SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation Ortho Spine News

Si-Bone (SIBN) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Si-Bone (SIBN) Reports Q2 Loss, Beats Revenue Estimates Yahoo Finance

SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods - Ortho Spine News

SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods Ortho Spine News

SI-BONE, Inc. Receives FDA 510(k) Clearance for iFuse - GlobeNewswire

SI-BONE, Inc. Receives FDA 510(k) Clearance for iFuse GlobeNewswire

The effect of minimally invasive sacroiliac joint fusion compared to sham operation: a double-blind randomized placebo-controlled trial - The Lancet

The effect of minimally invasive sacroiliac joint fusion compared to sham operation: a double-blind randomized placebo-controlled trial The Lancet

French National Healthcare System Adopts Exclusive Reimbursement Policy for SI-BONE, Inc.’s iFuse-3D Implant System - Ortho Spine News

French National Healthcare System Adopts Exclusive Reimbursement Policy for SI-BONE, Inc.’s iFuse-3D Implant System Ortho Spine News

New Study Confirms Sacrix® Fully Threaded Screw Outperforms SI-Bone's iFuse® Implant by 300% in Fixation Strength - Yahoo Finance

New Study Confirms Sacrix® Fully Threaded Screw Outperforms SI-Bone's iFuse® Implant by 300% in Fixation Strength Yahoo Finance

SI-BONE, Inc. Announces Publication of iFuse-3D Implant Clinical Study Results Showing Accelerated Fusion, Immediate and Sustained Clinical Improvements and Reduction in Opioid Use – Ortho Spine News - Ortho Spine News

SI-BONE, Inc. Announces Publication of iFuse-3D Implant Clinical Study Results Showing Accelerated Fusion, Immediate and Sustained Clinical Improvements and Reduction in Opioid Use – Ortho Spine News Ortho Spine News

SI-BONE, Inc. Announces FDA Clearance and Full U.S. Commercial Launch of the iFuse-3D™ Implant, a Patented, 3D-Printed Next Generation Member of the iFuse Implant System® - PR Newswire

SI-BONE, Inc. Announces FDA Clearance and Full U.S. Commercial Launch of the iFuse-3D™ Implant, a Patented, 3D-Printed Next Generation Member of the iFuse Implant System® PR Newswire

Sacroiliac joint stability: Finite element analysis of implant number, orientation, and superior implant length - Baishideng Publishing Group

Sacroiliac joint stability: Finite element analysis of implant number, orientation, and superior implant length Baishideng Publishing Group

SI-BONE Receives Additional Clearance for iFuse System - Orthopedics This Week

SI-BONE Receives Additional Clearance for iFuse System Orthopedics This Week

Santa Clara company's hip fracture tech gains momentum - The Business Journals

Santa Clara company's hip fracture tech gains momentum The Business Journals

FDA Clears SI BONE’s Latest SI Fusion Innovation - Orthopedics This Week

FDA Clears SI BONE’s Latest SI Fusion Innovation Orthopedics This Week

Earnings call transcript: Si-Bone Q2 2025 beats earnings expectations - Investing.com

Earnings call transcript: Si-Bone Q2 2025 beats earnings expectations Investing.com

Wall Street Analysts See a 34.22% Upside in Si-Bone (SIBN): Can the Stock Really Move This High? - Yahoo Finance

Wall Street Analysts See a 34.22% Upside in Si-Bone (SIBN): Can the Stock Really Move This High? Yahoo Finance

Si-Bone wins FDA clearance, breakthrough nod for pelvic fixation implant - MassDevice

Si-Bone wins FDA clearance, breakthrough nod for pelvic fixation implant MassDevice

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023 - Stock Titan

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023 Stock Titan

Si-Bone launches iFuse Bedrock Granite Implant system - MassDevice

Si-Bone launches iFuse Bedrock Granite Implant system MassDevice

Si-Bone: Q4 Earnings Snapshot - qz.com

Si-Bone: Q4 Earnings Snapshot qz.com

23 Payers Now Cover SI-BONE’s iFuse, Exclusively - Orthopedics This Week

23 Payers Now Cover SI-BONE’s iFuse, Exclusively Orthopedics This Week

Si-Bone touts first human case with pelvic fracture fixation device - MassDevice

Si-Bone touts first human case with pelvic fracture fixation device MassDevice

SI-BONE, Inc.: Coverage Revision Milestones! - Orthopedics This Week

SI-BONE, Inc.: Coverage Revision Milestones! Orthopedics This Week

Real-World Evidence: SI-BONE’s Innovative Spinopelvic Study Update - TipRanks

Real-World Evidence: SI-BONE’s Innovative Spinopelvic Study Update TipRanks

Si-Bone wins expanded FDA clearance for iFuse Bedrock Granite implant - MassDevice

Si-Bone wins expanded FDA clearance for iFuse Bedrock Granite implant MassDevice

Dunn, director at Si-Bone, sells $5,090 in SIBN stock - Investing.com

Dunn, director at Si-Bone, sells $5,090 in SIBN stock Investing.com

BCBS Rating Clears Way for SI-BONE’s iFuse Coverage - Orthopedics This Week

BCBS Rating Clears Way for SI-BONE’s iFuse Coverage Orthopedics This Week

SI-BONE stock price target reiterated at $25 by Cantor Fitzgerald - Investing.com

SI-BONE stock price target reiterated at $25 by Cantor Fitzgerald Investing.com

SI-BONE: New Positive Local Coverage Determination - Orthopedics This Week

SI-BONE: New Positive Local Coverage Determination Orthopedics This Week

Daniel Denis, MD, Performs Ochsner’s First Sacroiliac Joint Fusion with the iFuse Implant System - Biz New Orleans

Daniel Denis, MD, Performs Ochsner’s First Sacroiliac Joint Fusion with the iFuse Implant System Biz New Orleans

Si-Bone director Jeffrey W. Dunn sells $5,562 in common stock - Investing.com

Si-Bone director Jeffrey W. Dunn sells $5,562 in common stock Investing.com

SI-BONE: iFuse Shines in RCT - Orthopedics This Week

SI-BONE: iFuse Shines in RCT Orthopedics This Week

Top SI-Bone Executives Cash In on Stock Sales! - TipRanks

Top SI-Bone Executives Cash In on Stock Sales! TipRanks

Have Insiders Sold SI-BONE Shares Recently? - Sahm

Have Insiders Sold SI-BONE Shares Recently? Sahm

Insiders At SI-BONE Sold US$3.0m In Stock, Alluding To Potential Weakness - Sahm

Insiders At SI-BONE Sold US$3.0m In Stock, Alluding To Potential Weakness Sahm

Spinal implant manufacturer SI-BONE files for a $98 million IPO - Nasdaq

Spinal implant manufacturer SI-BONE files for a $98 million IPO Nasdaq

SI-BONE Receives Clearance from FDA to Release the iFuse-3D Implant in US - VoxelMatters

SI-BONE Receives Clearance from FDA to Release the iFuse-3D Implant in US VoxelMatters

Laura Francis to move up to CEO spot at Si-Bone - MassDevice

Laura Francis to move up to CEO spot at Si-Bone MassDevice

SI-Bone burrows into public markets with $108m IPO - - Global Corporate Venturing

SI-Bone burrows into public markets with $108m IPO - Global Corporate Venturing

SI-BONE: Three New Studies on iFuse - Orthopedics This Week

SI-BONE: Three New Studies on iFuse Orthopedics This Week

SI-BONE, Inc. (SIBN) Stock Analysis: Analyst Ratings Point To A Promising 59% Upside - DirectorsTalk Interviews

SI-BONE, Inc. (SIBN) Stock Analysis: Analyst Ratings Point To A Promising 59% Upside DirectorsTalk Interviews

First 3D Printed Titanium Implant for the Sacroiliac Joint, the iFuse-3D Implant, Gets FDA Clearance - 3DPrint.com

First 3D Printed Titanium Implant for the Sacroiliac Joint, the iFuse-3D Implant, Gets FDA Clearance 3DPrint.com

Tony Recupero New CCO at SI-BONE - Orthopedics This Week

Tony Recupero New CCO at SI-BONE Orthopedics This Week

What is SI BONE Inc. company’s growth strategy - Post Market Target Finder For Every Investor - Jammu Links News

What is SI BONE Inc. company’s growth strategy - Post Market Target Finder For Every Investor Jammu Links News

Top Si-Bone Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant